Abiomed plans €100M investment to triple production in Aachen by 2027

Abiomed plans to invest nearly €100 million by 2027 to triple production of Impella heart pumps at its Aachen site. The expansion includes a 7,700 m² building, a new parking garage, and a logistics center in Würselen, doubling the workforce to 600.

“Um die Produktion zu verdreifachen, sind bis 2027 Investitionen von fast 100 Millionen Euro geplant.”medlife-ev.de

• 1 source
• medlife-ev.deAbiomed investiert 100 Millionen Euro bis 2027Dec 13, 2023

Summarized from public sources; check the original articles before acting on it.